Floatz logo

Dcvac/Ovca

Epithelial Ovarian Carcinoma

Peking University Third HospitalPhase 2Active
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Epithelial Ovarian Carcinoma cohort.

Asset / SponsorPhaseRating
STAPULDENCEL
Peking University Third Hospital
Phase 2B
N-Acetyl-L-Cysteine
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B
Lurbinectedin
PharmaMar
Phase 1/2CCC
Mdna11
Medicenna Therapeutics, Inc.
Phase 1/2CCC

Same molecule, other indications

Dcvac/Ovca is also rated in:

Peritoneal CarcinomaDormant
B
Indicative ·
60 / 100
View asset →
Ovarian NeoplasmsDormant
B
Indicative ·
57 / 100
View asset →
Ovarian CancerDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →